Henry Schein's fourth-quarter results reflect stable dental and medical end-markets.
On Tuesday, Henry Schein Inc. HSIC reported a fourth-quarter adjusted EPS of $1.19, up 80.3% year-over-year, missing the consensus of $1.21.
Henry Schein (HSIC) came out with quarterly earnings of $1.19 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.66 per share a year ago.
Henry Schein forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid persistent inflation.
Besides Wall Street's top -and-bottom-line estimates for Henry Schein (HSIC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
Henry Schein is expected to report impressive sales in both its businesses in the fourth quarter of 2024, along with a positive pace of recovery from the cyber incident.
Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein , arguing the dental and medical distributor needs to start searching for a new CEO, cut costs and optimize capital allocation, three sources familiar with the matter said.
Henry Schein completes the acquisition of Acentus, which expands the former's Home Solution business.
Henry Schein has strategically set up distribution centers worldwide to better serve customers and increase its operating efficiency.
Investors are optimistic about HSIC owing to the performance of its dental business.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?